David I. Scheer
Fondateur chez Scheer & Co., Inc.
Profil
David I.
Scheer is the founder.
He founded Optherion, Inc. in 2005 and served as Chairman.
He also founded OraPharma, Inc. in 1996 and served as Director.
In 1998, he founded Esperion Therapeutics, Inc. and served as Director.
In 2003, he founded Tengion, Inc. and served as Chairman.
In 2005, he founded Aegerion Pharmaceuticals, Inc. and served as an Independent Director.
In 1981, he founded Scheer & Co., Inc. and currently serves as President.
Mr. Scheer is also the founder of Sopherion Therapeutics LLC.
Mr. Scheer's current job(s) include Vice Chairman & Secretary at Global Virus Network, Chairman at Arrett Neuroscience, Inc., Director-Biomedical & Interventional Technologies at Yale University, Director at Connecticut United for Research Excellence, Inc., and Member at NYU Langone Health.
Mr. Scheer's former job(s) include Chairman at Renetx Bio, Inc. from 2009 to 2017, Chairman at Angiochem, Inc. from 2010 to 2016, Vice Chairman at Long Wharf Theatre from 2012 to 2013, Director at Shire ViroPharma, Inc. from 1994 to 1997, Director at Achillion Pharmaceuticals, Inc. from 1998 to 2020, and Member-Leadership Council at Harvard T.H.
Chan School of Public Health.
Mr. Scheer's education history includes a graduate degree from Yale University and an undergraduate degree from Harvard College.
Postes actifs de David I. Scheer
| Sociétés | Poste | Début |
|---|---|---|
Scheer & Co., Inc.
 Scheer & Co., Inc. Investment ManagersFinance Scheer & Co., Inc. ( Scheer ) is a venture capital firm. The firm is founded in 1981 by David I. Scheer. The firm is headquartered in Connecticut, United States. | Fondateur | 25/05/2010 |
Connecticut United for Research Excellence, Inc.
 Connecticut United for Research Excellence, Inc. Miscellaneous Commercial ServicesCommercial Services Connecticut United for Research Excellence, Inc. intends to promote public understanding on the benefits of vaccines and medicines that are being offered by bioscience companies. Its members include biomedical research and educational institutions, biotechnology companies, health professionals, and healthcare systems. The company was founded on August 31, 1990 and is headquartered in New Haven, CT. | Directeur/Membre du Conseil | 14/07/2010 |
| Yale University | Corporate Officer/Principal | - |
NYU Langone Health
 NYU Langone Health Packaged SoftwareTechnology Services NYU Elaine A. & Kenneth G. Langone Medical Center provides health care services. It offers treatments for bone, joint, and muscle disorders; brain and nervous system disorders cancers, tumors and blood disorders; genetic and chromosomal disorders and immune system disorders. The company was founded in 1841 and is headquartered in New York, NY. | Corporate Officer/Principal | - |
| Arrett Neuroscience, Inc. | Président | - |
Global Virus Network
 Global Virus Network Miscellaneous Commercial ServicesCommercial Services Global Virus Network conducts research on essential and critical defense against viral diseases. The non-profit company is based in Baltimore, MD. The company was founded by William Walmsley Hall and Robert C. Gallo. | Directeur/Membre du Conseil | - |
Anciens postes connus de David I. Scheer
| Sociétés | Poste | Fin |
|---|---|---|
| ACHILLION PHARMACEUTICALS, INC. | Président | 03/01/2019 |
| AEGERION PHARMACEUTICALS, INC. | Fondateur | 01/01/2018 |
Renetx Bio, Inc.
 Renetx Bio, Inc. BiotechnologyHealth Technology Renetx Bio, Inc. operates as a biotechnology company that develops disease modifying therapeutics. It offers Nogo Receptor and Cellular Prion Protein technology. The company was founded by Sylvia McBrinn and Stephen Strittmatter in 2009 and is headquartered in New Haven, CT. | Président | 01/04/2017 |
| ░░░░░░░░░░ ░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░ ░░░░ | ░░░░░░░░░ | ░░░░░░░░░░ |
Formation de David I. Scheer
| Yale University | Graduate Degree |
| Harvard College | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| ESPERION THERAPEUTICS, INC. | Health Technology |
| TENGION, INC. | Health Technology |
| Entreprise privées | 14 |
|---|---|
Shire ViroPharma, Inc.
 Shire ViroPharma, Inc. Pharmaceuticals: MajorHealth Technology Shire ViroPharma, Inc. develops and manufactures drugs. It offers treatment for prophylaxis of hereditary angioedema, as well as capsules for the treatment of antibiotic associated pseudomembranous colitis caused by Clostridium difficile infection (CDI) and enterocolitis. The company was founded by Claude H. Nash and Mark A. McKinlay in September 1994 and is headquartered in Exton, PA. | Health Technology |
OraPharma, Inc.
 OraPharma, Inc. Pharmaceuticals: MajorHealth Technology OraPharma, Inc. develops and produces drugs for oral diseases. It offers a suite of products to address a range of patient concerns from the foundation of gums, bone, and teeth to the aesthetics of a whiter smile. The company's products include ARESTIN Microspheres, a locally administered antibiotic indicated as an adjunct to scaling and root planning procedures for the reduction of pocket depth in patients with adult periodontitis; and ONSET Approach, a unique delivery system of locally buffered anesthesia that provides faster onset of anesthesia and a comfortable injection. The company was founded in 1996 and is headquartered in Horsham, PA. | Health Technology |
Achillion Pharmaceuticals, Inc.
 Achillion Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Achillion Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of oral small molecule complement system inhibitors. Its pipeline includes Danicopan and ACH-5228. The company was founded on August 17, 1998 and is headquartered in Blue Bell, PA. | Health Technology |
Sopherion Therapeutics LLC
 Sopherion Therapeutics LLC BiotechnologyHealth Technology Sopherion Therapeutics LLC develops and commercializes anti-cancer therapies. The company was founded by Ronald H. Goldfarb and Salvatore Forenza in 2002 and is headquartered in Princeton, NJ. | Health Technology |
Aegerion Pharmaceuticals, Inc.
 Aegerion Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Aegerion Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in the development and commercialization of therapies for patients with debilitating rare diseases. The company was founded by David I. Scheer, Gerald L. Wisler and William H. Lewis in 2005 and is headquartered in Cambridge, MA. | Health Technology |
Optherion, Inc.
 Optherion, Inc. Medical SpecialtiesHealth Technology Optherion, Inc. develops therapeutic products. It develops products to diagnose and treat dry and wet Age-related Macular Degeneration and other chronic diseases involving the alternative complement system. The company was founded by Gregory S. Hageman, David I. Scheer and Sandy Gordon in 2005 and is headquartered in New Haven, CT. | Health Technology |
Renetx Bio, Inc.
Renetx Bio, Inc. BiotechnologyHealth Technology Renetx Bio, Inc. operates as a biotechnology company that develops disease modifying therapeutics. It offers Nogo Receptor and Cellular Prion Protein technology. The company was founded by Sylvia McBrinn and Stephen Strittmatter in 2009 and is headquartered in New Haven, CT. | Health Technology |
Angiochem, Inc.
 Angiochem, Inc. Pharmaceuticals: MajorHealth Technology Angiochem, Inc. is a clinical-stage biotechnology company, which engages in the development of pharmaceutical drugs for brain diseases and brain-related disorders. It offers small molecules and biologics, for the treatment of central nervous system diseases including primary brain cancer, brain metastases, lysosomal storage diseases, and pain. The company founded by Richard Béliveau in 2003 and is headquartered in Montreal, Canada. | Health Technology |
Connecticut United for Research Excellence, Inc.
Connecticut United for Research Excellence, Inc. Miscellaneous Commercial ServicesCommercial Services Connecticut United for Research Excellence, Inc. intends to promote public understanding on the benefits of vaccines and medicines that are being offered by bioscience companies. Its members include biomedical research and educational institutions, biotechnology companies, health professionals, and healthcare systems. The company was founded on August 31, 1990 and is headquartered in New Haven, CT. | Commercial Services |
Scheer & Co., Inc.
Scheer & Co., Inc. Investment ManagersFinance Scheer & Co., Inc. ( Scheer ) is a venture capital firm. The firm is founded in 1981 by David I. Scheer. The firm is headquartered in Connecticut, United States. | Finance |
| Long Wharf Theatre | |
NYU Langone Health
NYU Langone Health Packaged SoftwareTechnology Services NYU Elaine A. & Kenneth G. Langone Medical Center provides health care services. It offers treatments for bone, joint, and muscle disorders; brain and nervous system disorders cancers, tumors and blood disorders; genetic and chromosomal disorders and immune system disorders. The company was founded in 1841 and is headquartered in New York, NY. | Technology Services |
Global Virus Network
Global Virus Network Miscellaneous Commercial ServicesCommercial Services Global Virus Network conducts research on essential and critical defense against viral diseases. The non-profit company is based in Baltimore, MD. The company was founded by William Walmsley Hall and Robert C. Gallo. | Commercial Services |
| Arrett Neuroscience, Inc. |
